1. Home
  2. NFLX vs MRK Comparison

NFLX vs MRK Comparison

Compare NFLX & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Netflix Inc.

NFLX

Netflix Inc.

N/A

Current Price

$67.56

Market Cap

368.4B

ML Signal

N/A

Logo Merck & Company Inc. (new)

MRK

Merck & Company Inc. (new)

N/A

Current Price

$124.58

Market Cap

317.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NFLX
MRK
Founded
1997
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.4B
317.8B
IPO Year
2000
1994

Fundamental Metrics

Financial Performance
Metric
NFLX
MRK
Price
$67.56
$124.58
Analyst Decision
Strong Buy
Buy
Analyst Count
34
17
Target Price
$119.23
$125.59
AVG Volume (30 Days)
40.4M
7.3M
Earning Date
04-16-2026
04-30-2026
Dividend Yield
N/A
3.06%
EPS Growth
N/A
8.01
EPS
2.03
N/A
Revenue
$45,183,036,000.00
$65,011,000,000.00
Revenue This Year
$15.99
$3.61
Revenue Next Year
$11.74
$5.41
P/E Ratio
$33.33
N/A
Revenue Growth
15.85
1.31
52 Week Low
$65.08
$76.66
52 Week High
$1,267.10
$131.74

Technical Indicators

Market Signals
Indicator
NFLX
MRK
Relative Strength Index (RSI) 27.63 51.44
Support Level N/A $112.68
Resistance Level $78.44 $130.29
Average True Range (ATR) 2.10 3.26
MACD -0.35 -0.41
Stochastic Oscillator 16.35 34.33

Price Performance

Historical Comparison
NFLX
MRK

About NFLX Netflix Inc.

Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

About MRK Merck & Company Inc. (new)

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Share on Social Networks: